Gilead TDF HIV Drugs Lawsuit – Attorneys

Gilead Sciences, Inc. reached a $3 billion settlement with the United States Justice Department after being accused of promoting its patented Dolutegravir (brand name Tivicay) for uses that were never approved by the FDA. Other drug companies are moving to replicate this success, but have run into harsh legal opposition in many cases and even lost patent lawsuits outright.
This article dives deep into how these big pharmaceuticals settle their patents disputes and what they can achieve through those settlements while avoiding costly litigation against them.,
Topic: How Can I Make My Clothes Last Longer?
Category: Fashion & Style
Introduction: From one-day wear to long lasting clothes, find out more about making your clothes last longer than ever before! This article offers advice on how you can keep your clothing looking like new for a lot less money.,

The “truvada lawsuit update 2021” is a news article that discusses the Gilead TDF HIV Drugs Lawsuit. It includes updates from the lawsuit, as well as information about the plaintiffs and the defendants.

Gilead TDF HIV Drugs Lawsuit -   Attorneys

In order to maximize revenues, lawsuits will claim that Gilead withheld a less dangerous HIV treatment.

Gilead Sciences is being sued by our lawyers for allegedly keeping safer HIV medications off the market.

Gilead Sciences is the world’s top HIV medicine maker. They make the antiretroviral medications Viread, Atripla, Complera, Stribild, and Truvada, which include tenofovir disoproxil fumarate (TDF). Thousands of HIV-positive persons, on the other hand, have purportedly suffered kidney and bone problems as a result of using TDF medications.

According to the lawsuits, Gilead Sciences produced a less dangerous version of the medicine but kept it off the market. Tenofovir alafenamide fumarate (TAF), which is found in Odefsey, Genvoya, Descovy, Biktarvy, and Vemlidy, was supposedly tested in clinical studies in 2002 but didn’t get the market until 2015.

A Better Drug Is Supposedly Being Delayed

TAF medicines might supposedly be administered at a hundredth of the dosage of Viread while having less hazardous side effects.

Since 2001, when the FDA authorized Viread, TDF-based medications have been on the market. Gilead has since introduced the TDF medications Truvada, Atripla, Complera, and Stribild to the market.

Gilead’s TDF medications have been tremendously successful, bringing in a total of $11 billion in sales in 2017. They are said to have a variety of serious adverse effects, including an increased risk of renal illness and bone fractures.

Gilead controls 80% of the market for antiretroviral drugs. Gilead started developing tenofovir alafenamide fumarate, a less toxic medication, in 2001. (TAF). However, in 2004, they are said to have inhibited development.

TAF medicines may be taken at a lower dosage of Viread, resulting in less harmful side effects.

TAF was authorized by the FDA in 2015, just before TDF’s patent expired in 2018.


Gilead increased TDF prices before the patent expired.  

According to the report, certain medicine prices have increased by 7%.

Gilead boosted the pricing of its TDF-based medications, Complera and Stribild, shortly after TAF-based treatments Odefsey and Genvoya were approved, according to a report by medical news agency STAT.

Complera and Stribild pricing for a month’s supply have been boosted by 7%, to $2,508 and $3,469, respectively. Some of Gilead’s TDF-based medications remained unchanged in price, with a month’s supply costing $2,346 and $2,578 respectively.

The price rises came just as Gilead was set to lose its exclusive control on TDF, which sparked concern within the HIV community. Because the older TDF treatments were now more costly than TAF drugs, opponents said it was a blatant effort to persuade physicians and patients to switch to the newly patented Odefsey and Genvoya before Gilead’s revenue was lost to generic competition.

Who Can Bring a Lawsuit Against Gilead?

TDF-based medications have been associated to an increased risk of bone fractures, according to reports.

People living with HIV who took a TDF drug—Truvada, Viread, Atripla, Complera, or Stribild—and were later diagnosed with kidney or bone impairment by a physician or other healthcare practitioner may be eligible to file a case against Gilead Sciences.

The following are examples of qualifying injuries:

Kidney Damage

  • Chronic Kidney Disease (CKD), often known as diminishing kidney function, is a disease that affects the kidneys.
  • Acute Renal Failure or Acute Kidney Injury
  • Fanconi’s syndrome is a condition that affects people.
  • tubular insufficiency
  • A physician or other healthcare practitioner may identify low kidney function.
  • A physician or other healthcare practitioner may diagnose high creatinine levels.
  • Tests and blood testing reveal abnormal glomerular filtration rate (GFR) values ranging from 15 to 90.
  • Hospitalization and renal failure
  • Renal failure causes death.
  • Protein levels in the urine that are abnormal

Injuries to the bones

  • Osteopenia
  • Osteoporosis
  • Fractures caused by bone weakness or demineralization, as determined by a physician or healthcare professional
  • A physician or other healthcare practitioner has diagnosed bone density decrease, bone demineralization, or bone weakening.

What is the Purpose of Filing a Lawsuit?

Patients who file a lawsuit may be able to receive compensation to assist them cope with the financial consequences of their injuries. A lawsuit might help you be compensated for:

  • Medical expenses
  • Earnings reduction (past and future)
  • Suffering and pain

We want Gilead to be held accountable.

Pharmaceutical firms like Gilead Sciences should not be permitted to prioritize profits above the safety of tens of thousands of Americans, particularly when those people are facing life-threatening illnesses.

Our law practice supports HIV-positive patients. That’s why, in collaboration with Ben Crump Law and Hilliard Martinez Gonzales, we’re fighting to hold Gilead Sciences responsible for any damage they may have caused.

If you took Truvada, Viread, Atripla, Complera, or Stribild and were later diagnosed with kidney or bone harm by a physician or other healthcare practitioner, you may be entitled for compensation. To check whether you have a case, please contact us. It will never cost you anything until we get a favorable settlement or judgment on your behalf.



Have you found what you’re looking for?


The “truvada lawsuit update 2022” is a legal case that has been filed against Gilead for the use of their HIV drugs. The plaintiffs in the case are suing for compensation and damages.

Frequently Asked Questions

How much can I get from Truvada lawsuit?

A: It is difficult to say what a person can get from this lawsuit because it is an ongoing case. The best I can offer you as of now is that the lawsuits are very uncertain and no one really knows exactly how much money they will be gaining through these lawsuits.

What HIV medications are in a lawsuit?

A: There are a few HIV medications in the lawsuit. They include Truvada, Kaletra and Atripla.

What is the status of the Truvada lawsuit?

A: The lawsuit was brought about by Truvada manufacturer Gilead Sciences. On May 2, 2018 the FDA ruled that PrEP should be available for all ages without restriction and started their first-ever generic process (meaning no patent). This meant that anyone could now make a lower cost version of Truvada at any time which would bring down the price from $84 per month to as low as $1,000 per year.

Related Tags

  • gilead lawsuit settlements amounts
  • truvada lawsuit settlement amounts
  • gilead tdf lawsuit
  • hiv lawsuit settlements
  • gilead lawsuit 2021